Neuronetics Inc. (STIM) Prices 4.84M Share Common Offering at $15.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
After-Hours Stock Movers 01/28: (KOSS) (GME) (NVAX) Higher; (EVLO) (ADMP) (JNP) Lower (more...)
January 28, 2021 6:00 PM ESTToday's After-Hours Stock Movers:
Koss Corporation (NASDAQ: KOSS) 47.9% HIGHER; Robinhood will again allow limited trades
GameStop Corp. (NYSE: GME) 35% HIGHER; Robinhood will again allow limited trades
Novavax, Inc. (Nasdaq: NVAX) 29% HIGHER; announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical... More
Neuronetics (STIM) Announces Proposed Public Offering of Common Stock
January 28, 2021 4:02 PM ESTNeuronetics, Inc. (NASDAQ: STIM) (the Company), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has commenced an underwritten public offering of its... More
Neuronetics (STIM) PT Raised to $23 at JMP Securities
January 27, 2021 2:42 AM ESTJMP Securities analyst David Turkaly raised the price target on Neuronetics (NASDAQ: STIM) to $23.00 (from $15.00) while maintaining a Market Outperform rating.... More

